Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial.

Sunita KumariArka DeNaveen KalraVirendra Singh

Published in: The American journal of gastroenterology (2023)

Long-term use of GH is safe in DC and leads to improvement in malnutrition and possibly QOL. However, there is no improvement in 12-month survival. (NCT03420144).

Keyphrases

growth hormone
heart failure
double blind
open label
dendritic cells
placebo controlled
phase ii
atrial fibrillation
randomized controlled trial
mesenchymal stem cells
immune response
bone marrow
smoking cessation
liver failure
ejection fraction